Regeneron Raised to $851 By Morgan Stanley; Zscaler Boosted to $210 By RBC Capital | Price Target Changes
Morgan Stanley raised the price target on Regeneron Pharmaceuticals, Inc. from $625 to $851. Morgan
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial